Related Experiment Video
Updated: Jul 10, 2025
07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.2K
A Patient Charter for Chronic Urticaria.
Marcus Maurer1,2, Mónica Albuquerque3, Jean-Nicolas Boursiquot4
1Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Advances in Therapy
|November 22, 2023
Summary
Chronic urticaria (CU) impacts quality of life and healthcare costs. A patient charter outlines 5 principles for accurate diagnosis, specialty care, innovative treatments, minimal side effects, and holistic management of chronic urticaria.
Area of Science:
- Dermatology
- Immunology
- Public Health
Background:
- Chronic urticaria (CU) affects 1.4% globally, characterized by recurrent wheals/angioedema lasting over 6 weeks.
- CU significantly impairs daily activities, sleep, and quality of life, imposing financial burdens on patients and healthcare systems.
- Patient self-advocacy and improved communication are crucial for effective CU diagnosis and management.
Purpose of the Study:
- To introduce a patient charter outlining 5 core principles for optimal chronic urticaria care.
- To empower patients in navigating their CU diagnosis and treatment journey.
- To guide healthcare providers, policymakers, and guideline authors in improving patient outcomes for chronic urticaria.
Main Methods:
- A collaborative effort involving patients, providers, advocacy groups, and pharmaceutical representatives.
- Development of a patient charter detailing 5 key principles of expected care for chronic urticaria.
- Dissemination of principles to guide patient-provider communication and healthcare policy.
Main Results:
- The patient charter establishes 5 principles: timely diagnosis, access to specialty care, innovative treatments, minimized side effects, and holistic care.
- These principles aim to improve patient-provider communication and enhance the overall management of chronic urticaria.
- The charter serves as a framework for achieving patient-centered goals in CU care.
Conclusions:
- The patient charter provides a roadmap for achieving realistic and achievable care standards for individuals with chronic urticaria.
- Implementing these principles can lead to better patient-physician communication and improved outcomes.
- Urging policymakers and guideline authors to consider these patient-centered principles is essential for advancing CU management.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
412
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
412
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:19Antiasthma Drugs: Leukotriene Modifiers
321
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
321
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
307
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
307
01:27Nursing Ethical Principles II
985
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
985
01:20COPD: Pathogenesis and Clinical Features
294
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
294